Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
49,010,949
-
Share change
-
-3,232,286
-
Total reported value
-
$635,371,815
-
Put/Call ratio
-
142%
-
Price per share
-
$12.96
-
Number of holders
-
162
-
Value change
-
-$42,000,595
-
Number of buys
-
87
-
Number of sells
-
71
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2021
As of 30 Jun 2021,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,010,949 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PICTET ASSET MANAGEMENT LTD, KINGDON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, Artal Group S.A., and WELLS FARGO & COMPANY/MN.
This page lists
162
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.